Zobair Younossi
Appearances
- DateMay 7, 2023Background: Nonalcoholic steatohepatitis (NASH) is a major cause of liver-related morbidity, mortality, and the leading indication for liver transplant in the US. Fibrosis is the best predictor of clinical outcomes in NASH…
- DateMay 9, 2023Symptoms such as intractable pruritus, cramping and fatigue are the most impactful to a patients quality of life and often the most challenging manage. This session provides expert guidance in helping patients with these issues…
Presenter
- DateMay 9, 2023Symptoms such as intractable pruritus, cramping and fatigue are the most impactful to a patients quality of life and often the most challenging manage. This session provides expert guidance in helping patients with these issues…
Presenters
- DateMay 20, 2024BACKGROUND AND AIM: Metabolic dysfunction-associated steatotic liver disease (MASLD) has been used to rename nonalcoholic fatty liver disease (NAFLD)…